Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoff S Higgins

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Journal of Neuro-Oncology|November 26, 2022
The role of [<sup>18</sup>F]fluorodopa positron emission tomography in grading of gliomasJoy R Roach, Puneet Plaha, Daniel R McGowan, et al.
Frontiers in Oncology|February 4, 2020
Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?Joseph D Wilson, Ester M Hammond, Geoff S Higgins, et al.
British Journal of Cancer|August 10, 2023
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunitiesNicole D Machado, Lisa C Heather, Adrian L Harris, et al.
Cancer Treatment Reviews|January 13, 2015
Drug radiotherapy combinations: review of previous failures and reasons for future optimismGeoff S Higgins, Sean M O'Cathail, Ruth J Muschel, et al.
Scientific Reports|December 16, 2022
Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patientsPauline Bourigault, Michael Skwarski, Ruth E Macpherson, et al.
Cell Death & Disease|October 26, 2018
T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeuticsKatharine J Herbert, Thomas M Ashton, Remko Prevo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2018
Oxidative Phosphorylation as an Emerging Target in Cancer TherapyThomas M Ashton, W Gillies McKenna, Leoni A Kunz-Schughart, et al.
EJNMMI Research|December 29, 2021
Investigation of atovaquone-induced spatial changes in tumour hypoxia assessed by hypoxia PET/CT in non-small cell lung cancer patientsPauline Bourigault, Michael Skwarski, Ruth E Macpherson, et al.
Oncotarget|August 12, 2010
Overexpression of POLQ confers a poor prognosis in early breast cancer patientsGeoff S Higgins, Adrian L Harris, Remko Prevo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 31, 2021
Associations between cardiac irradiation and survival in patients with non-small cell lung cancer: Validation and new discoveries in an independent datasetSindu Vivekanandan, John D Fenwick, Nicholas Counsell, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Journal of Neuro-Oncology|November 26, 2022
The role of [<sup>18</sup>F]fluorodopa positron emission tomography in grading of gliomasJoy R Roach, Puneet Plaha, Daniel R McGowan, et al.
Frontiers in Oncology|February 4, 2020
Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?Joseph D Wilson, Ester M Hammond, Geoff S Higgins, et al.
British Journal of Cancer|August 10, 2023
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunitiesNicole D Machado, Lisa C Heather, Adrian L Harris, et al.
Cancer Treatment Reviews|January 13, 2015
Drug radiotherapy combinations: review of previous failures and reasons for future optimismGeoff S Higgins, Sean M O'Cathail, Ruth J Muschel, et al.
Scientific Reports|December 16, 2022
Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patientsPauline Bourigault, Michael Skwarski, Ruth E Macpherson, et al.
Cell Death & Disease|October 26, 2018
T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeuticsKatharine J Herbert, Thomas M Ashton, Remko Prevo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2018
Oxidative Phosphorylation as an Emerging Target in Cancer TherapyThomas M Ashton, W Gillies McKenna, Leoni A Kunz-Schughart, et al.
EJNMMI Research|December 29, 2021
Investigation of atovaquone-induced spatial changes in tumour hypoxia assessed by hypoxia PET/CT in non-small cell lung cancer patientsPauline Bourigault, Michael Skwarski, Ruth E Macpherson, et al.
Oncotarget|August 12, 2010
Overexpression of POLQ confers a poor prognosis in early breast cancer patientsGeoff S Higgins, Adrian L Harris, Remko Prevo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 31, 2021
Associations between cardiac irradiation and survival in patients with non-small cell lung cancer: Validation and new discoveries in an independent datasetSindu Vivekanandan, John D Fenwick, Nicholas Counsell, et al.
Pageof 6